Reports the synthesis of hybrid compounds combining pharmacophores from NN703 (an oral GHS derived from ipamorelin) and ipamorelin itself, yielding unexpectedly potent in vitro and in vivo GH-releasing activity. Advances structure-activity understanding for developing orally bioavailable GH secretagogues.
Hansen, T K; Ankersen, M; Raun, K; Hansen, B S